logo
Share SHARE
FONT-SIZE Plus   Neg

CryoPort Names Stephen Wasserman To Board - Quick Facts

CryoPort, Inc. (CYRX.OB) on Thursday said it has named Stephen Wasserman, 65, to its Board of Directors. He replaces Carlton Johnson, who resigned from the Board earlier this month.

CryoPort provides cold chain frozen shipping systems primarily to the biotechnology, pharmaceutical, and life science industries. Wasserman has over 30 years of senior operating and financial management experience in the medical device and healthcare industries.

Wasserman is currently on the Board of the medical diagnostics firm Iris International and serves as chairman of the compensation committee.

Previously he was group vice president of the Diagnostic Systems Products division of medical technology firm Olympus America as well as a member of the executive committee for American Operations.

Larry Stambaugh, CryoPort's chairman and chief executive officer, said, "Stephen's experience managing highly successful medical device and diagnostic companies will be extremely valuable to CryoPort as we accelerate our commercial activities this year. We look forward to drawing on Stephen's in-depth knowledge of our target markets and his proven ability to drive the introduction of new technologies and products."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
HSBC is reportedly laying off about 100 of its senior investment bankers worldwide, as the banking giant strives to curb operating costs. According to reports, the London-headquartered bank will eliminate managing director and director level employees at the Global Banking and Markets division, as... Samsung Electronics Co., Ltd. (SMSN.L, SSNNF.OB, SSNLF.OB) will reportedly blame faulty batteries for last year's Galaxy Note 7 fiasco. According to a Wall Street Journal report, Samsung's investigation of Galaxy Note 7 smartphones found that some batteries were irregularly sized while others had... Federal investigators have closed their probe of a fatal crash that involved a Tesla Motors Inc. car eight months ago. The regulators said they have found no safety defects in the vehicle's automated driving system and that Tesla's Autopilot-enabled vehicles did not need to be recalled.
comments powered by Disqus
Follow RTT